Prostate Cancer Risk in Relation to a Single Nucleotide Polymorphism in the Insulin-like Growth Factor-binding Protein-3 (IGFBP3) Gene: a Meta-analysis

Yeqing Mao(First Affiliated Hospital Zhejiang University), Liping Xie(First Affiliated Hospital Zhejiang University), Xianglai Xu(Fudan University), Zhenghui Hu(First Affiliated Hospital Zhejiang University), Xiangyi Zheng(Tianjin University), Hong Chen(First Affiliated Hospital Zhejiang University), Yi Zhu(Mayo Clinic in Arizona), Jian Wu(National Yang Ming Chiao Tung University), Jie Qin(Shanghai Medical College of Fudan University), Xin Xu(Shanghai University of Sport), Yiwei Lin(First Affiliated Hospital Zhejiang University)
Asian Pacific Journal of Cancer Prevention
December 31, 2012
10.7314/apjcp.2012.13.12.6299
Cited by 6

Related Papers

The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer
|Molecular Cancer|2020|383
Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis
|World Journal of Surgical Oncology|2019|276
Downregulation of N6-methyladenosine binding YTHDF2 protein mediated by miR-493-3p suppresses prostate cancer by elevating N6-methyladenosine levels
|Oncotarget|2017|207
Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells <i>in vitro</i> and inhibits tumor growth <i>in vivo</i>
|Cancer Science|2009|188